aluminum hydroxide 40 MG/ML / magnesium hydroxide 40 MG/ML / simethicone 4 MG/ML Oral Suspension [Mintox Plus]
RxNorm concept 210037, branded drug (sbd). Prescribable name: Mintox 200 MG / 200 MG / 20 MG in 5 mL Oral Suspension.
- RxCUI
- 210037
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/210037 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Mintox Plus (aluminum hydroxide 200 MG / magnesium hydroxide 200 MG / simethicone 20 MG) per 5 ML Oral Suspension; Mintox Plus (aluminum hydroxide 40 MG/ML / magnesium hydroxide 40 MG/ML / simethicone 4 MG/ML) Oral Suspension
Related concepts
- aluminum hydroxide 40 MG/ML (SCDC, consists of)
- magnesium hydroxide 40 MG/ML (SCDC, consists of)
- simethicone 4 MG/ML (SCDC, consists of)
- aluminum hydroxide 40 MG/ML / magnesium hydroxide 40 MG/ML / simethicone 4 MG/ML [Mintox Plus] (SBDC, consists of)
- Oral Suspension (DF, has dose form)
- Mintox Plus (BN, has ingredient)
- aluminum hydroxide 40 MG/ML / magnesium hydroxide 40 MG/ML / simethicone 4 MG/ML Oral Suspension (SCD, tradename of)
Linked data
NDCs
- 17856572103
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 210037 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/210037 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 210037. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.